Free Trial

Bicara Therapeutics (BCAX) Institutional Ownership

Bicara Therapeutics logo
$18.09 +0.32 (+1.80%)
(As of 11/22/2024 ET)

Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)

Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$396.56M
Number of
Institutional Sellers
(last 12 months)
0
Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BCAX Institutional Buying and Selling by Quarter

Bicara Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024 Barclays PLC10,000$255K0.0%N/A0.018%
11/18/2024 Teachers Retirement System of The State of Kentucky14,039$358K0.0%N/A0.026%
11/16/2024 Geode Capital Management LLC48,639$1.24M0.0%N/A0.094%
11/15/2024 Barclays PLC10,000$255K0.0%N/A0.019%
11/15/2024 Jane Street Group LLC12,151$309K0.0%N/A0.023%
11/15/2024 Wellington Management Group LLP763,943$19.46M0.0%N/A1.476%
11/15/2024 Soros Fund Management LLC20,000$509K0.0%N/A0.039%
11/15/2024 Samsara BioCapital LLC35,000$891K0.2%N/A0.068%
11/15/2024 RA Capital Management L.P.6,955,993$177.17M2.0%N/A13.439%
11/15/2024 Point72 DIFC Ltd55,757$1.42M0.0%N/A0.108%
11/15/2024 Point72 Asset Management L.P.371,962$9.47M0.0%N/A0.719%
11/15/2024 Maven Securities LTD50,000$1.27M0.0%N/A0.097%
11/15/2024 Iron Triangle Partners LP200,000$5.09M0.7%N/A0.386%
11/15/2024 Janus Henderson Group PLC1,188,191$30.33M0.0%N/A2.296%
11/15/2024 Cinctive Capital Management LP9,001$229K0.0%N/A0.017%
11/15/2024 Baker BROS. Advisors LP833,333$21.23M0.2%N/A1.610%
11/15/2024 Point72 Asia Singapore Pte. Ltd.18,125$462K0.1%N/A0.035%
11/14/2024 Braidwell LP1,657,600$42.22M1.2%N/A3.202%
11/14/2024 Vestal Point Capital LP425,000$10.83M0.8%N/A0.821%
11/14/2024 Walleye Capital LLC31,780$809K0.0%N/A0.061%
11/13/2024 FMR LLC2,273,792$57.91M0.0%N/A4.393%
11/13/2024 The Manufacturers Life Insurance Company 22,859$582K0.0%N/A0.044%
11/7/2024 First Turn Management LLC562,391$14.32M2.3%N/A1.087%
(Data available from 1/1/2016 forward)

BCAX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCAX shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), FMR LLC ($57.91M), Braidwell LP ($42.22M), Janus Henderson Group PLC ($30.33M), Baker BROS. Advisors LP ($21.23M), Wellington Management Group LLP ($19.46M), and First Turn Management LLC ($14.32M).Learn more on BCAX's institutional investors.

Which institutional investors have been buying Bicara Therapeutics stock?

Of the 22 institutional investors that purchased Bicara Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), FMR LLC ($2.27M), Braidwell LP ($1.66M), Janus Henderson Group PLC ($1.19M), Baker BROS. Advisors LP ($833.33K), Wellington Management Group LLP ($763.94K), and First Turn Management LLC ($562.39K).

How much institutional buying is happening at Bicara Therapeutics?

Institutional investors have bought a total of 15,569,556 shares in the last 24 months. This purchase volume represents approximately $396.56M in transactions.



This page (NASDAQ:BCAX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners